Scinovex
Subscribe
M

Michael A. Nauck

Universitätsklinikum Knappschaftskrankenhaus BochumORCID https://orcid.org/0000-0002-5749-6954
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—

Top Publications

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
New England Journal of Medicine20167,103 citations
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Diabetes Care20123,208 citations
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care20143,061 citations
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Journal of Clinical Investigation19931,635 citationsFirst authorCorresponding
Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes
Diabetologia19861,298 citationsFirst authorCorresponding
Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients
Diabetologia19931,087 citationsFirst authorCorresponding
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
American Journal of Physiology-Endocrinology and Metabolism1997816 citationsFirst authorCorresponding
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Diabetologia2015688 citations
Michael A. Nauck · Scinovex